Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026

What the insiders did Net buying

By person

19 insiders · 213 transactions
12.0×

Nadim Ahmed holds 12.0 times base salary in stock. $8.43M of shares against $698.48K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadim Ahmed last reported holding, valued at $21.57, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Bvf Partners L P/Il entity
10% owner
$21.30M (10)
—
+$21.30M
64,161
0.0997%
$1.38M
−98.5%
Lynx1 Capital Management LP entity
10% owner
$13.32M (8)
—
+$13.32M
8,963,500
13.93%
$193.34M
+26.4%
Vision SCS F2
10% owner
—
$4.76M (7)
−$4.76M
1,255,963
1.95%
$27.09M
−56.9%
Jennifer Michaelson
Chief Scientific Officer
—
$4.71M (51) scheduled
−$4.71M
158,844
0.2468%
$3.43M
+537.2%
Morana Jovan-Embiricos
10% owner
$4.20M (2)
—
+$4.20M
312,565
0.4857%
$6.74M
—
Leigh Zawel
See Remarks
—
$3.09M (10)
−$3.09M
69,785
0.1084%
$1.51M
−53.4%
Ansbert Gadicke
Director
$6.30M (1)
$8.85M (38)
−$2.55M
23,612,189
36.69%
$509.31M
+50.2%
Corrine Savill
Chief Business Officer
—
$2.54M (9) scheduled
−$2.54M
240,990
0.3745%
$5.20M
+24.8%
UBS Oncology Impact Fund L.P. entity
10% owner
$6.30M (1)
$7.77M (19)
−$1.47M
7,648,268
11.88%
$164.97M
—
F2 Bioscience I 2017 Ltd entity
10% owner
—
$1.30M (3)
−$1.30M
537,392
0.8350%
$11.59M
−15.9%
Nadim Ahmed
President and CEO
$100.32K (1)
$794.17K (10)
−$693.85K
390,803
0.6073%
$8.43M
—
Jeffrey Trigilio
Chief Financial Officer
$47.25K (1)
$689.70K (13) scheduled
−$642.45K
133,919
0.2081%
$2.89M
—
Patrick Baeuerle
Chief Scientific Officer
—
$609.95K (2) scheduled
−$609.95K
417,434
0.6486%
$9.00M
+22.3%
Jeffrey Alan Jones
Chief Medical Officer
—
$309.61K (11)
−$309.61K
159,968
0.2486%
$3.45M
—
Jacquelyn L Sumer
Chief Legal Officer
—
$235.65K (11)
−$235.65K
130,559
0.2029%
$2.82M
+6,373%
Mary Kay Fenton
Chief Financial Officer
—
$59.90K (1)
−$59.90K
127,921
0.1988%
$2.76M
+6,293%
Owen Hughes
President and CEO
$52.50K (1)
—
+$52.50K
506,226
0.7866%
$10.92M
+0.5%
Thomas Ebeling
Director
—
—
—
186,653
0.2900%
$4.03M
+176.5%
Raymond T Keane
Chief Legal Officer
—
—
—
24,124
0.0375%
$520.35K
+1,385%